Clinical Trials Logo

Filter by:
  • Not yet recruiting  
  • « Prev · Page [21]
NCT ID: NCT01029093 Not yet recruiting - Clinical trials for Injury of the Right Upper Extremity

Effects of Sensory and Motor Deprivation on Brain Plasticity

Start date: December 2009
Phase: N/A
Study type: Observational

Investigation of changes in gray and white matter during immoblisation after injury of the right upper extremity via two MR Investigations of the brain at two different times.

NCT ID: NCT00720967 Not yet recruiting - Clinical trials for Cardiovascular Disease

Preop Hemodialysis or Intraop Ultrafiltration for Patients With Severe Renal Dysfunction Undergoing Open Heart Surgery

SeRenaD-CPB
Start date: November 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether preoperative hemodialysis or intraoperative modified ultrafiltration are effective for patients with non-dialysis dependent severe renal dysfunction undergoing open heart surgery.

NCT ID: NCT00641355 Not yet recruiting - Sepsis Clinical Trials

Acute Phase Proteins as Early Markers in Sepsis

Start date: April 2008
Phase: N/A
Study type: Observational

Monitoring of different serumproteins after severe trauma and during trauma-induced sepsis. - Trial with surgical intervention

NCT ID: NCT00521482 Not yet recruiting - Glioblastoma Clinical Trials

Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma

Start date: September 2007
Phase: Phase 2
Study type: Interventional

The aim of this study is to evaluate the efficacy and safety of intensive dose temozolomide treatment alone in parallel to a combination with thalidomide in patients with recurrent glioblastoma after standard therapy. In the treatment arm A of the study it will be investigated whether or not continuous dosing of temozolomide may overcome alkylator resistance in patients with glioblastoma who progress on the 5/28 day dosing regimen. For treatment arm B it is postulated that the combination of thalidomide and temozolomide is effective with respect to time to progression and progression-free survival due to the fact that temozolomide and thalidomide have different mechanisms of action.

NCT ID: NCT00391339 Not yet recruiting - Tocolysis Clinical Trials

Bryophyllum vs. Nifedipine

Start date: November 2006
Phase: Phase 2/Phase 3
Study type: Interventional

In a prospective, randomised study the efficacy and tolerability of bryophyllum p. (p.o) vs. nifedipine (p.o) will be proofed in a defined group of pregnant women with threatened preterm labour.